Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Puma Biotechnology, Inc. (PBYI)
Price$9.44Cached quote
Net income
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2011
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $228.4M | $230.5M | $235.6M | $228.0M | $253.2M | $225.1M | $272.3M | $251.0M | $27.7M | — | — | — | — | — | — |
| Gross profit | $170.2M | $166.1M | $173.0M | $172.9M | $189.5M | $185.7M | $235.4M | $216.4M | $22.1M | — | — | — | — | — | — |
| Gross margin | 74.53% | 72.06% | 73.40% | 75.84% | 74.84% | 82.51% | 86.48% | 86.21% | 79.87% | — | — | — | — | — | — |
| Research & development | $62.1M | $54.9M | $50.4M | $52.2M | $71.9M | $97.7M | $132.9M | $164.9M | $207.8M | $222.8M | $208.5M | $122.9M | $45.0M | $49.6M | $826,000 |
| Operating expenses | $191.1M | $199.5M | $203.0M | $204.3M | $251.9M | $255.5M | $311.3M | $345.6M | $320.1M | $276.6M | $240.3M | $142.3M | $54.8M | $74.5M | $10.2M |
| Operating income | $37.3M | $31.0M | $32.6M | $23.7M | $1.3M | −$30.4M | −$39.0M | −$94.7M | −$292.4M | −$276.6M | −$240.3M | −$142.3M | −$54.8M | −$74.5M | −$10.2M |
| Operating margin | 16.33% | 13.44% | 13.85% | 10.40% | 0.51% | −13.51% | −14.34% | −37.71% | −1,056.13% | — | — | — | — | — | — |
| EBITDA | $48.2M | $42.5M | $44.2M | $33.6M | $12.6M | −$20.4M | −$31.0M | −$87.3M | −$289.6M | −$275.4M | −$239.5M | −$141.6M | −$54.4M | −$74.2M | −$10.1M |
| EBITDA margin | 21.12% | 18.44% | 18.74% | 14.72% | 4.98% | −9.05% | −11.37% | −34.77% | −1,045.98% | — | — | — | — | — | — |
| Net income | $31.1M | $30.3M | $21.6M | $2,000 | −$29.1M | −$60.0M | −$75.6M | −$113.6M | −$292.0M | −$276.0M | −$239.3M | −$142.0M | −$54.7M | −$74.4M | −$10.2M |
| Net profit margin | 13.62% | 13.14% | 9.16% | 0.00% | −11.51% | −26.65% | −27.77% | −45.25% | −1,054.56% | — | — | — | — | — | — |
| Basic EPSper basic share | $0.62 | $0.62 | $0.46 | $0.00 | -$0.72 | -$1.52 | -$75,595.00 | -$2.99 | -$7.85 | -$8.29 | -$7.45 | -$4.73 | -$1.90 | -$3.42 | -$1.32 |
| Diluted EPSper diluted share | $0.61 | $0.62 | $0.45 | $0.00 | -$0.72 | -$1.52 | -$1.95 | -$2.99 | -$7.85 | -$8.29 | -$7.45 | -$4.73 | -$1.90 | -$3.42 | -$1.32 |
Owners
Reported shareholders
≈14.30%of listed shares
AUERBACH ALAN H7.31M shares · Feb 18, 2026
View holders
| Holder | % owned |
|---|---|
AUERBACH ALAN H | ≈14.30%7.31M shares |
ACORN CAPITAL ADVISORS, LLC | 8.08%4.13M shares |
BlackRock, Inc. | 7.45%3.8M shares |
AMERICAN CENTURY COMPANIES INC | 4.54%2.32M shares |
ACADIAN ASSET MANAGEMENT LLC | 4.02%2.05M shares |
RENAISSANCE TECHNOLOGIES LLC | 3.59%1.84M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.59%1.84M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 3.57%1.83M shares |
LSV ASSET MANAGEMENT | 3.17%1.62M shares |
DIMENSIONAL FUND ADVISORS LP | 2.97%1.52M shares |
GEODE CAPITAL MANAGEMENT, LLC | 2.62%1.34M shares |
O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 2.20%1.12M shares |
STATE STREET CORP | 1.86%952.17K shares |
KENNEDY CAPITAL MANAGEMENT LLC | 1.71%873.25K shares |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1.55%791.62K shares |
RITHOLTZ WEALTH MANAGEMENT | 1.47%749.8K shares |
AQR CAPITAL MANAGEMENT LLC | 1.42%725.19K shares |
GOLDMAN SACHS GROUP INC | 1.31%669.16K shares |
NORTHERN TRUST CORP | 1.28%652.39K shares |
Connor, Clark & Lunn Investment Management Ltd. | 1.26%642.95K shares |
Percentages use 51.1M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026Form 4 · 10b5-1 | WILSON TROY EDWARDDirector | SellCommon Stock | 10.8K | $7.20 | $77.8K | 59.8K |
| Jun 12, 2026Form 4 · 10b5-1 | Stuglik Brian MDirector | SellCommon Stock | 8.1K | $7.20 | $58.3K | 113.9K |
| Jun 12, 2026Form 4 · 10b5-1 | Senderowicz AdrianDirector | SellCommon Stock | 27.0K | $7.20 | $194.4K | 27.0K |
| Jun 12, 2026Form 4 · 10b5-1 | MOYES JAY MDirector | SellCommon Stock | 22.0K | $7.22 | $158.8K | 58.3K |
| Jun 12, 2026Form 4 · 10b5-1 | Dorval AllisonDirector | SellCommon Stock | 11.6K | $7.20 | $83.6K | 90.8K |